15-100208916-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_139057.4(ADAMTS17):​c.1076-9493G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.683 in 151,856 control chromosomes in the GnomAD database, including 35,625 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 35625 hom., cov: 30)

Consequence

ADAMTS17
NM_139057.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.57

Publications

5 publications found
Variant links:
Genes affected
ADAMTS17 (HGNC:17109): (ADAM metallopeptidase with thrombospondin type 1 motif 17) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. [provided by RefSeq, May 2016]
ADAMTS17 Gene-Disease associations (from GenCC):
  • Weill-Marchesani 4 syndrome, recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Orphanet, Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.721 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139057.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTS17
NM_139057.4
MANE Select
c.1076-9493G>A
intron
N/ANP_620688.2Q8TE56-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTS17
ENST00000268070.9
TSL:1 MANE Select
c.1076-9493G>A
intron
N/AENSP00000268070.4Q8TE56-1
ADAMTS17
ENST00000961098.1
c.1076-9493G>A
intron
N/AENSP00000631157.1
ADAMTS17
ENST00000568565.2
TSL:5
c.1076-9493G>A
intron
N/AENSP00000456161.2H3BRA9

Frequencies

GnomAD3 genomes
AF:
0.683
AC:
103659
AN:
151738
Hom.:
35618
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.657
Gnomad AMI
AF:
0.690
Gnomad AMR
AF:
0.643
Gnomad ASJ
AF:
0.635
Gnomad EAS
AF:
0.569
Gnomad SAS
AF:
0.741
Gnomad FIN
AF:
0.715
Gnomad MID
AF:
0.679
Gnomad NFE
AF:
0.710
Gnomad OTH
AF:
0.676
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.683
AC:
103699
AN:
151856
Hom.:
35625
Cov.:
30
AF XY:
0.683
AC XY:
50692
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.657
AC:
27181
AN:
41398
American (AMR)
AF:
0.643
AC:
9818
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.635
AC:
2204
AN:
3470
East Asian (EAS)
AF:
0.568
AC:
2916
AN:
5138
South Asian (SAS)
AF:
0.741
AC:
3565
AN:
4810
European-Finnish (FIN)
AF:
0.715
AC:
7540
AN:
10540
Middle Eastern (MID)
AF:
0.676
AC:
196
AN:
290
European-Non Finnish (NFE)
AF:
0.710
AC:
48232
AN:
67926
Other (OTH)
AF:
0.675
AC:
1419
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1625
3250
4875
6500
8125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.698
Hom.:
37810
Bravo
AF:
0.676
Asia WGS
AF:
0.679
AC:
2363
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.0
DANN
Benign
0.35
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1480952; hg19: chr15-100749121; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.